Zobrazeno 1 - 10
of 65
pro vyhledávání: '"G. Sarosy"'
Publikováno v:
Gay Men and Aging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb49ec902a1eb54542c176f1e4437e52
https://doi.org/10.4324/9781003249351-4
https://doi.org/10.4324/9781003249351-4
Publikováno v:
Gay Men and Aging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a912157d171bd179e39f0fc2a86cfafd
https://doi.org/10.4324/9781003249351-5
https://doi.org/10.4324/9781003249351-5
Autor:
C L Fortner, Clagett-Carr K, D. E. Hoth, Brian Leyland-Jones, D. Macfarlane, Larry Rubinstein, Brenda J. Foster, G. Sarosy, Peter J. O'Dwyer, B. R. Davies, D. Dale Shoemaker, H. G. Chun
Publikováno v:
Annals of Oncology. 3:59-62
Summary The special exception mechanism was established by the Division of Cancer Treatment (DCT), National Cancer Institute (NCI), for the provision of anticancer drugs not yet approved by the Food and Drug Administration (FDA) to patients on a comp
Autor:
W D, Figg, M C, Christian, R, Lush, C J, Link, P, Davis, E, Kohn, G, Sarosy, M L, Rothenberg, R B, Weiss, N, Ryan, J, Jacobs, E, Reed
Publikováno v:
Biopharmaceuticsdrug disposition. 18(4)
Preclinical data suggest that ormaplatin (tetrachloro-(dl-trans)-1, 2-diamminocyclohexaneplatinum) has substantial activity in cisplatin-resistant tumor models and may be less nephrotoxic than cisplatin. Based on these data we initiated a phase I cli
Autor:
E C, Kohn, E, Reed, G, Sarosy, M, Christian, C J, Link, K, Cole, W D, Figg, P A, Davis, J, Jacob, B, Goldspiel, L A, Liotta
Publikováno v:
Cancer research. 56(3)
Carboxyamido-triazole (CAI) is a synthetic inhibitor of non-excitable calcium channels that reversibly inhibits angiogenesis, tumor cell proliferation, and metastatic potential. Inhibition of calcium influx and calcium-dependent events is a potential
Publikováno v:
Seminars in oncology. 22(3 Suppl 6)
The three most active types of agents in the treatment of cancer of the ovary are platinum compounds (cisplatin or carboplatin), bifunctional alkylating agents (cyclophosphamide, melphalan, etc), and the recently developed natural product paclitaxel
Publikováno v:
Journal of the National Medical Association. 85(6)
Taxol is the most exciting new anticancer agent developed in the past two decades. Of great interest is its level of activity in ovarian cancer, as well as substantial activity in breast cancer, nonsmall-cell lung cancer, melanoma, and other malignan